Sachin S. Bhagwat
Aurangabad, MH, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Nafithromycin in CABP: promise and precaution-authors' reply.
Journal: The Lancet regional health. Southeast Asia
Published: October 30, 2025
Pharmacokinetics and Penetration of a Novel Pharmacodynamically Optimized, Carbapenem-Sparing Antibiotic, WCK 4282 (Cefepime/Tazobactam), into Epithelial Lining Fluid of Healthy, Lung-, and Thigh-Infected Neutropenic Mice.
Journal: Microbial drug resistance (Larchmont, N.Y.)
Published: September 11, 2025
Efficacy and safety of a 3-day once-daily regimen of oral nafithromycin in comparison to oral moxifloxacin for the treatment of community-acquired bacterial pneumonia in adults: a phase III, randomized, double-blind controlled trial.
Journal: The Lancet regional health. Southeast Asia
Published: April 15, 2025
Serum Pharmacokinetics and Bone Penetration of Novel Broad-Spectrum Anti-MRSA Agent Levonadifloxacin in Wistar Rats.
Journal: Microbial drug resistance (Larchmont, N.Y.)
Published: October 03, 2024
Transcending the challenge of evolving resistance mechanisms in Pseudomonas aeruginosa through β-lactam-enhancer-mechanism-based cefepime/zidebactam.
Journal: mBio
Published: October 27, 2023
Investigations on In Vivo Pharmacokinetic/Pharmacodynamic Determinants of Fosfomycin in Murine Thigh and Kidney Infection Models.
Journal: Microbial drug resistance (Larchmont, N.Y.)
Published: November 08, 2022
WCK 4034: A promising oxazolidinone for treating gram positive infections.
Journal: Bioorganic & medicinal chemistry letters
Published: March 24, 2022
WCK 1152, WCK 1153: Discovery and structure activity relationship for the treatment of resistant pneumococcal and staphylococcal respiratory infections.
Journal: Bioorganic & medicinal chemistry letters
Published: December 17, 2021
Ensuring robustness in the quality of antibiotic susceptibility test discs for four novel antibiotics.
Journal: Biomedical chromatography : BMC
Published: October 29, 2021
Design and synthesis of an oral prodrug alalevonadifloxacin for the treatment of MRSA infection.
Journal: Bioorganic & medicinal chemistry letters
Published: August 13, 2021
In Vitro Activity of Fosfomycin and Nitrofurantoin Against Contemporary Enterobacterales Pathogens Isolated from Indian Tertiary Care Hospitals.
Journal: Microbial drug resistance (Larchmont, N.Y.)
Published: May 13, 2021
Comment on: An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa.
Journal: The Journal of antimicrobial chemotherapy
Published: April 30, 2021
Last Updated: 09/26/2026